Published Date:2024-09-08 Original Link:https://www.onenessbio.com/en/news_detail317_1.htm No 1 Date of announcement 2024/09/08 Time of announcement 17:16:12 Subject SNS812 Phase 2 study demonstrated statistical significance in treating COVID-19 based on its safety, precision and broad-spectrum efficacy. To which item it meets paragraph 10 Date of events 2024/09/06 Statement Date of occurrence of the event: 2024/09/06 New drug name...Read More

Published Date:2024-09-08 Original Link:https://www.onenessbio.com/en/news_detail318_1.htm No 2 Date of announcement 2024/09/08 Time of announcement 18:18:59 Subject Oneness & Microbio (Shanghai) host an international press conference to present the pan-COVID new drug, SNS812 Phase 2 clinical trial results and future prospects To which item it meets paragraph 53 Date of events 2024/09/08 Statement Date of occurrence of...Read More